IAAF 2017 IAAF vs Suleiman Kipses Simotwo
February 27, 2018
In July 2017 the IAAF Athletics Integrity Unit (AIU) has reported an anti-doping rule violation against the Kenyan Athlete Suleiman Kipses Simotwo after his sample tested positive for the prohibited substance 19-norandrosterone (Nandrolone). After notification a provisional suspension was ordered. The Athlete filed a statement in his defence and was heard for the IAAF Disciplinary Tribunal Panel.
The Athlete denied the intentional use of the substance and stated that he was tested before without issues.
He suggested that something may have happened when he was in a district hospital in December 2016. He testified that he became unconscious and suffered an injury due to a fall in the bath. In the hospital he underwent treatment and left it with some medication.
The AIU contended that the Athlete statement did not explain his positive test about 4 months later.
The Panel finds that the Athlete failed to establish how the substance entered his system nor did he demonstrate with evidence that his hospital treatment in December 2016 caused the positive test result.
The Panel concludes that het evidence establish that the Athlete has committed the anti-doping rule violation without grounds for a reduced sanction.
Therefore the IAAF Disciplinary Tribunal Panel decides on 27 February 2018 to impose a 4 year period on the Athlete, starting on the date of the provisional suspension, i.e. on 14 July 2017.
